AMLX — AMYLYX PHARMACEUTICALS INC

Ownership history in STEMPOINT CAPITAL LP  ·  3 quarters on record

This page tracks every 13F SEC filing in which STEMPOINT CAPITAL LP reported a position in AMYLYX PHARMACEUTICALS INC (AMLX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
1.17% (2025 Q4)
Avg. % of fund
0.75%
First filed
2023 Q4
Last filed
2025 Q4
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q4 ADDED 565,140 +288,256 +104.1% 1.17% $6.8M $12.08
2025 Q3 ADDED 276,884 +193,503 +232.1% 0.75% $3.8M $13.59
2023 Q4 INITIATED 83,381 — — 0.33% $1.2M —
% of Fund (quarterly)    AMLX price (monthly, adj. close)

Other funds also holding AMLX

As of 2025 Q4 — sorted by position size

Saturn V Capital Management LP 3Y 9.97% GREAT POINT PARTNERS LLC 3Y 7Y 6.85% Almitas Capital LLC 3Y 7Y 5.65% Commodore Capital LP 3Y 4.54% First Light Asset Management, LLC 3Y 7Y 3.1% ACUTA CAPITAL PARTNERS, LLC 3Y 7Y 2.73% TCG Crossover Management, LLC 3Y 2.5% Aldebaran Capital, LLC 3Y 2.15% PERCEPTIVE ADVISORS LLC 3Y 7Y 1.78% Patient Square Capital LP 3Y 0.91%
← Back to STEMPOINT CAPITAL LP Holdings